10g,100g, 1kg Aluminum Foil bag/25kg drum/ bottle or negotiation
Shipped in 3 days after payment
Loss On Drying
PRL-8-53 is a popular synthetic nootropic agent. It is a novel monoamine that is identified as 3-(2-benzylmethylamino ethyl) benzoic acid methyl ester hydrochloride. It is a derivative of benzoic acid comprised of the phenethylamine skeleton. Its unique structural properties meet the criteria required for cholinergic receptors interaction. Experimental animal studies have shown that PRL-8-53 produces cholinergic responses.
PRL-8-53 is considered as a nootropic agent that remains to be a research compound to date. It was developed and patented by Dr. Nikolaus Hansl during the 1970s while he was working at Creighton University. The acronym PRL came from its previous patent holder Pacific Research Labs. Please note that there is very little published clinical research done to evaluate the effects and safety of this chemical agent. These published studies are even undertaken by the creator himself which might present bias towards its efficiency. For this reason, it is advised that one exercise precautions with this research nootropic compound. Despite the lack of supporting literature however, anecdotal reports appear very favorable.
Packaging & Shipping
Packaging: 10g,100g, 1kg Aluminum Foil bag/25kg drum/ bottle or negotiation
Delivery: Always deliver in one working day after receiving your payment if we have stock.